Cancer Research Annual Meeting 2010  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 6353-6359, December 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chan, R.
Right arrow Articles by Cardiff, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, R.
Right arrow Articles by Cardiff, R. D.

Presence of Proteolytically Processed Keratins in the Culture Medium of MCF-7 Cells1

Raymond Chan, Paul V. Rossitto, Benjamin F. Edwards and Robert D. Cardiff2

Department of Medical Pathology, School of Medicine, University of California, Davis, California 95616

MCF-7 human mammary epithelial cells are known to express three distinct cytoskeletal intermediate filament proteins designated numbers 8 (Mr 52,000), 18 (Mr 45,000), and 19 (Mr 40,000) keratin. Using a panel of monoclonal antibodies and peptide mapping, we have determined that MCF-7 cells release proteolytic derivatives of keratins 18 and 19 into the culture medium. These extracellular keratins consist of multiple isoforms (Mr 38,000–45,000, isoelectric point 5.0–5.2) on two-dimensional gels, many of which are smaller and more acidic than the predominant intracellular forms and appear to be associated together as a soluble, large molecular weight complex. These results may potentially be correlated with observations of keratin-like antigens in body fluids of cancer patients and the presence of antikeratin antibodies in individuals with certain autoimmune diseases and acute viral infections.

1 This work is supported by a grant from Triton Biosciences, Inc.

2 To whom requests for reprints should be addressed.

Received 4/ 7/86. Revised 7/14/86. Accepted 8/20/86.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H. J. Ditzel, M. C. M. Strik, M. K. Larsen, A. C. Willis, A. Waseem, K. Kejling, and J. C. Jensenius
Cancer-associated Cleavage of Cytokeratin 8/18 Heterotypic Complexes Exposes a Neoepitope in Human Adenocarcinomas
J. Biol. Chem., June 7, 2002; 277(24): 21712 - 21722.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. J. Ditzel, U. Garrigues, C. B. Andersen, M. K. Larsen, H. J. Garrigues, A. Svejgaard, I. Hellstrom, K. E. Hellstrom, and J. C. Jensenius
Modified cytokeratins expressed on the surface of carcinoma cells undergo endocytosis upon binding of human monoclonal antibody and its recombinant Fab fragment
PNAS, July 22, 1997; 94(15): 8110 - 8115.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
T. Hembrough, J Vasudevan, M. Allietta, W. Glass, and S. Gonias
A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines
J. Cell Sci., January 3, 1995; 108(3): 1071 - 1082.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.